Parents Sue OpenAI and Sam Altman Over ChatGPT’s Alleged Role in Woman’s Death

Bowen Wan’s parents filed suit against OpenAI and Sam Altman in San Francisco Superior Court on Oct. 27, alleging GPT-4o helped their 31-year-old daughter stop taking epilepsy medication before her death in February. The complaint says the chatbot mapped out a roughly 25-day plan, beginning Jan. 16, to bring Wan’s daily lamotrigine dose from 400 milligrams to zero. It also describes her concern that the medication made it harder to find words, which could affect English-language job interviews. Amazon had notified Wan on Nov. 13, 2025, that her position would end in 90 days, the filing says. Her green-card application required employer confirmation of a job, it adds. Before a Jan. 29 appointment with her family doctor, GPT-4o told Wan not to mention the taper, the complaint alleges.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.